U.S. Stock News

Ardelyx (ARDX) stock is in focus after the company reported second quarter 2026 results on 6 August, showing higher revenue, narrower net losses, and updated full year guidance for IBSRELA and XPHOZAH. See our latest analysis for Ardelyx. Ardelyx’s recent earnings update came after a tough stretch for the stock, with the share price down 24.62% over the past month and 36.26% year to date, even though the 5 year total shareholder return of 166.67% still reflects a much stronger longer term...

Corporación América Airports has delivered a very large 337.9% total return over the past 5 years, yet after the recent pullback investors are facing a stock that screens as undervalued on the broad valuation checks. With the share price giving back some ground this year, the question is how that long term performance lines up with what the current multiples and fundamentals suggest. The 337.9% 5 year return highlights how strongly the stock has rewarded long term holders, which makes the...

Standex International has delivered a very strong 236.4% return over the past 5 years, yet the current valuation checks suggest the stock now leans expensive rather than being a clear bargain. The 236.4% gain over 5 years shows Standex International has rewarded long term holders and raises the bar for what future returns would need to justify today's price. Future revenue and cash flow growth from the core industrial businesses can support the current share price. However, any setback in...

Dividend change puts Hancock Whitney stock in focus Hancock Whitney (HWC) has drawn fresh investor attention after raising its annualized dividend by 11.1%, keeping the payout ratio at 33% and offering a yield above both the Banks - Southeast group and the S&P 500. See our latest analysis for Hancock Whitney. At a share price of $78.25, Hancock Whitney has seen its 90 day share price return of 17.39% and year to date share price return of 21.39% translate into a 1 year total shareholder...

PPL stock has returned 55.7% over the past three years, yet its broader valuation checks lean more cautious. This raises a question about how much upside is already reflected in the current share price. Recent headlines around a large Pennsylvania power venture with Blackstone add a new growth angle that investors now have to weigh against that weaker value score. PPL's 55.7% three year return points to investors already paying up for the company, so fresh gains may depend more on how the...

Supernus Pharmaceuticals stock has almost doubled over the past five years, yet the latest valuation checks still point to shares looking inexpensive on several measures. That mix of strong long term returns and a broadly cheap read on the fundamentals is what investors are now weighing. Supernus Pharmaceuticals has returned 95.3% over five years, which puts the recent price performance against a longer record of value creation. Growth in prescription volumes and product uptake would need to...

Morgan Stanley (NYSE:MS) faces a new lawsuit from a former advisor alleging workplace discrimination and misconduct by senior management. The complaint includes claims of gender and disability discrimination, as well as alleged breaches of confidential health information. The former advisor says the treatment and management conduct left her feeling forced to resign from the firm. These allegations highlight wider questions about culture and risk controls at large financial institutions...

In August 2026, Rocket Lab Corporation was onboarded to the U.S. Space Force’s US$981 million NITE-STAR IDIQ program, won a GEO satellite-bus role from Viasat for Protected Tactical SATCOM-Global, and confirmed successful on-orbit performance of eight Lightning-platform satellites built for MDA Space and Globalstar. Together with its recent at-the-market equity raises and acquisition push, these wins underline Rocket Lab’s shift toward becoming a vertically integrated space contractor...

MKS Inc. reported past second-quarter 2026 results with revenue of US$1,248 million and net income of US$175 million, alongside issuing third-quarter guidance for revenue of about US$1,350 million and GAAP net income of about US$201 million. Award recognition from key partner Zhen Ding Technology Group for Service Excellence and Technology Innovation highlights MKS’s role in AI-driven semiconductor and advanced packaging ecosystems. We’ll now examine how this Zhen Ding recognition for...

Government bond yields in the US and Europe have climbed to multi month highs, which puts fresh pressure on growth stocks and income seekers who rely on bonds. That shift pulls attention back to solid dividend payers. High yield Dividend Fortresses that offer 5%+ yields and resilient cash generation can look especially appealing. This article highlights three such stocks that aim to prioritise income and staying power. The three Dividend Fortresses in this article are just a starting sample,...

SouthState Bank recently expanded into Government Contractor Banking, appointing veteran banker and former MartinFederal Consulting CEO David Mathis to lead the new vertical and support clients with financing, treasury management, capital markets, and mergers and acquisitions services. This move introduces a specialized focus on the government contracting sector, pairing niche industry knowledge with commercial banking capabilities to broaden SouthState’s business banking offering. We’ll now...

Northwest Natural Holding (NWN) stock is in focus after the company reported second quarter 2026 results, swung to a small net profit, and guided full year earnings per share toward the upper half of its 2026 range. See our latest analysis for Northwest Natural Holding. Northwest Natural Holding shares have edged higher in recent months, with a 90 day share price return of 2.2% and a year to date share price return of 9.16%. The 1 year total shareholder return of 30.75% and 3 year total...

Relay Therapeutics has delivered a very large 1 year return, yet the stock currently screens as expensive on broad valuation checks, which raises questions about how much optimism is already in the price. Relay Therapeutics has returned roughly 7x over the past 12 months, which puts unusual weight on whether the fundamentals can justify that kind of move. Expectations for future drug development and potential revenue can support the current valuation, while uncertainty around clinical...

Curtiss-Wright (CW) extended its share repurchase activity on August 10, 2026, adding US$100 million to its buyback authorization and bringing the total program size to US$2.166 billion. See our latest analysis for Curtiss-Wright. Curtiss-Wright’s latest buyback expansion comes after a brief period of share price softness, with the stock down over the past quarter but still showing strong year to date share price returns and very strong multi year total shareholder returns. If this kind of...

Kinder Morgan stock has delivered strong returns over the past few years, yet the current price near US$32.87 is still below an intrinsic value estimate from a Discounted Cash Flow (DCF) approach that points to roughly 40.4% upside. At the same time, market multiples suggest Kinder Morgan is trading at about the right level overall, which creates a mixed read on how much value is really left in the share price today. Over the past 5 years Kinder Morgan has returned about 161.3%, which puts...

In early August 2026, STERIS plc reported first-quarter fiscal 2027 results showing higher sales of US$1,492.7 million and increased earnings, reiterated its full-year revenue growth guidance of 7% to 8%, appointed Pierre Boulud to key board committees, and announced a US$600 million chemistries Center of Excellence in North Carolina. The combination of earnings growth, reaffirmed guidance, and the largest manufacturing investment in the company’s history highlights management’s confidence...

The United States market remained flat over the last week but has seen a 20% increase over the past year, with earnings forecasted to grow by 17% annually. In this environment, identifying undervalued stocks like OceanFirst Financial can provide opportunities for investors seeking value in companies priced below their estimated worth.

In the last week, the United States market has remained flat, although it is up 20% over the past year with earnings forecasted to grow by 17% annually. In such a promising environment, growth companies with high insider ownership can be particularly appealing as insiders' confidence in their own firms often signals potential for sustained expansion and value creation.

Over the last 7 days, the United States market has remained flat, although it is up 20% over the past year, with earnings expected to grow by 17% per annum in the coming years. The term 'penny stocks' might feel like a relic of past market eras, but they continue to represent real potential for investors seeking affordability and growth when backed by strong financials. In this article, we will explore several penny stocks that stand out for their financial strength and potential for...

Brown-Forman stock has delivered a steep decline of about 56.6% over the past five years, yet its current checks suggest a more nuanced valuation picture where the Discounted Cash Flow (DCF) estimate points to meaningful upside while market multiples look closer to fair value. Over five years, Brown-Forman’s share price has fallen about 56.6%, which raises questions about whether expectations have reset too far compared to the company’s fundamentals. Future cash flow and margin expectations...

Verizon Communications (NYSE: VZ) has had its petition rejected by the U.S. Supreme Court, leaving in place a multimillion dollar FCC fine tied to sales of customers' real time location data. The decision ends Verizon's legal challenge and confirms the financial penalty imposed over its handling of sensitive user information. The outcome renews focus on Verizon's regulatory exposure and the privacy rules that apply to major U.S. telecom carriers. With regulators tightening their focus on...

Market discussion around TAL Education Group (NYSE:TAL) has picked up after commentators highlighted its lower PEG ratio and P/B ratio compared with peers. This has prompted investors to reassess the stock’s current pricing and earnings outlook. See our latest analysis for TAL Education Group. TAL Education Group's recent trading reflects this renewed interest, with a 1-month share price return of 17.48% and a 3-month share price return of 14.90% indicating building momentum. The 3-year total...

CBL & Associates Properties (CBL) is back in focus after its August earnings update, which showed higher quarterly and half year sales and net income, along with new full year 2026 earnings guidance. See our latest analysis for CBL & Associates Properties. At a share price of US$56.66, CBL & Associates Properties has cooled slightly in the very short term, yet a 30 day share price return of 2.51% and 90 day share price return of 18.73% sit alongside a year to date share price return of 53.43%...

In August 2026, Insmed Incorporated reported second-quarter 2026 results showing a net loss of US$13.24 million, down sharply from US$321.69 million a year earlier, with basic and diluted loss per share from continuing operations at US$0.06 versus US$1.70. Over the first half of 2026, Insmed’s net loss narrowed to US$176.81 million from a very large loss of US$578.27 million, suggesting meaningfully lower cash burn and tighter cost control compared with the prior year period. We’ll now...